GH1 and acromegaly: Circulating GH values are not useful as biochemical marker of Pegvisomant effects in acromegaly both because endogenous GH secretion may increase during treatment due to negative feedback and, particularly, due to cross-reactivity of GH with Pegvisomant in most GH assays [21] (HQ).